A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL
IntroductionAngioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma characterized by a T follicular helper cell phenotype expressing PD-1 (programmed cell death-1). AITL exhibits a poor response to conventional chemotherapy, with a me…